Co. Bids To Keep CVS Unit From Clients In Trade Secrets Row
RxStrategies, a leading program administrator for the federal 340B Drug Pricing Program, renewed its efforts Friday to stop CVS and its in-house administrator Wellpartner from allegedly misappropriating its trade secrets to...To view the full article, register now.
Already a subscriber? Click here to view full article